Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Innovent Starts Phase I Trial of CD47/PD-L1 Bispecific for Solid Tumor Cancers
Ascletis Approved to Market Dual All-oral HCV Treatment in China
Henlius' Herceptin Biosimilar Approved for European Use
NeuPharma Doses First Patient in Phase II Trial of Novel Inhibitor for Cancer
Chi-Med Starts China Phase I Trial of Ninth Novel Cancer Candidate
Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China